Related references
Note: Only part of the references are listed.Vaccine-induced COVID-19 mimicry syndrome
Eric Kowarz et al.
ELIFE (2022)
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
Natalija Novak et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2022)
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey
Vittorio Pengo et al.
RHEUMATOLOGY (2022)
The clinical significance of antiphospholipid antibodies in COVID-19 infection
Ebru Atalar et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2022)
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
Haoyu Pan et al.
RHEUMATOLOGY (2022)
Thrombosis and Coagulopathy in COVID-19
Juan Esteban Gomez-Mesa et al.
CURRENT PROBLEMS IN CARDIOLOGY (2021)
Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
Giuseppe Carli et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
David M. Smadja et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
Savino Sciascia et al.
LANCET RHEUMATOLOGY (2021)
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?
Rossella Talotta et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort
Tingting Liu et al.
SCIENCE BULLETIN (2021)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Epidemiology of SARS-CoV-2 infection and COVID-19
B. Salzberger et al.
INTERNIST (2020)
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature
Ying-Kiat Tan et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
Maria Orietta Borghi et al.
FRONTIERS IN IMMUNOLOGY (2020)
An update on the management of antiphospholipid syndrome
Mia Rodziewicz et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)
Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine
Mojca Bizjak et al.
SEMINARS IN HEMATOLOGY (2016)
Infections and vaccines in the etiology of antiphospholipid syndrome
Paola Cruz-Tapias et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome
A. Katzav et al.
LUPUS (2012)
Murine Monoclonal Antibody 26 Raised Against Tetanus Toxoid Cross-Reacts with beta(2)-Glycoprotein I: Its Characteristics and Role in Molecular Mimicry
Aleksandra Inic-Kanada et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Redox-reactive autoantibodies: Detection and physiological relevance
JA McIntyre et al.
AUTOIMMUNITY REVIEWS (2006)
Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin
M Vega-Ostertag et al.
ARTHRITIS AND RHEUMATISM (2004)